Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariano Esteban

Showing results (21-30 of 256) with videos related to

Pageof 26
Sort By:
Virus Research|August 25, 2004
Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gammaCarmen Elena Gómez, Fernando Abaitua, Dolores Rodríguez, et al.
Microbes and Infection|March 1, 2006
MVA-LACK as a safe and efficient vector for vaccination against leishmaniasisEva Pérez-Jiménez, Grazyna Kochan, M Magdalena Gherardi, et al.
Expert Review of Vaccines|October 31, 2013
Clinical applications of attenuated MVA poxvirus strainCarmen Elena Gómez, Beatriz Perdiguero, Juan García-Arriaza, et al.
Human Vaccines & Immunotherapeutics|August 22, 2012
Poxvirus vectors as HIV/AIDS vaccines in humansCarmen Elena Gómez, Beatriz Perdiguero, Juan Garcia-Arriaza, et al.
Current Gene Therapy|April 9, 2008
The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancerCarmen E Gómez, José L Nájera, Magdalena Krupa, et al.
Journal of Virology|February 1, 2005
Wiskott-Aldrich syndrome protein is needed for vaccinia virus pathogenesisSusana Guerra, Miguel Aracil, Raquel Conde, et al.
The Journal of General Virology|May 29, 2003
Evidence that avian reovirus sigmaA protein is an inhibitor of the double-stranded RNA-dependent protein kinaseClaudia González-López, José Martínez-Costas, Mariano Esteban, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization scheduleM Magdalena Gherardi, Eva Pérez-Jiménez, José Luis Nájera, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|December 24, 2005
Current situation in the development of a preventive HIV vaccineJosé Alcamí, Joan Joseph Munné, María Angeles Muñoz-Fernández, et al.
Oncogene|December 6, 2002
Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3LMaria Angel García, Susana Guerra, Jesús Gil, et al.
Pageof 26

Showing results (21-30 of 256) with videos related to

Sort By:
Pageof 26
Virus Research|August 25, 2004
Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gammaCarmen Elena Gómez, Fernando Abaitua, Dolores Rodríguez, et al.
Microbes and Infection|March 1, 2006
MVA-LACK as a safe and efficient vector for vaccination against leishmaniasisEva Pérez-Jiménez, Grazyna Kochan, M Magdalena Gherardi, et al.
Expert Review of Vaccines|October 31, 2013
Clinical applications of attenuated MVA poxvirus strainCarmen Elena Gómez, Beatriz Perdiguero, Juan García-Arriaza, et al.
Human Vaccines & Immunotherapeutics|August 22, 2012
Poxvirus vectors as HIV/AIDS vaccines in humansCarmen Elena Gómez, Beatriz Perdiguero, Juan Garcia-Arriaza, et al.
Current Gene Therapy|April 9, 2008
The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancerCarmen E Gómez, José L Nájera, Magdalena Krupa, et al.
Journal of Virology|February 1, 2005
Wiskott-Aldrich syndrome protein is needed for vaccinia virus pathogenesisSusana Guerra, Miguel Aracil, Raquel Conde, et al.
The Journal of General Virology|May 29, 2003
Evidence that avian reovirus sigmaA protein is an inhibitor of the double-stranded RNA-dependent protein kinaseClaudia González-López, José Martínez-Costas, Mariano Esteban, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization scheduleM Magdalena Gherardi, Eva Pérez-Jiménez, José Luis Nájera, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|December 24, 2005
Current situation in the development of a preventive HIV vaccineJosé Alcamí, Joan Joseph Munné, María Angeles Muñoz-Fernández, et al.
Oncogene|December 6, 2002
Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3LMaria Angel García, Susana Guerra, Jesús Gil, et al.
Pageof 26